Peter Böhlen

34.2k total citations · 11 hit papers
223 papers, 27.7k citations indexed

About

Peter Böhlen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Böhlen has authored 223 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 43 papers in Cellular and Molecular Neuroscience and 32 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Böhlen's work include Angiogenesis and VEGF in Cancer (45 papers), Fibroblast Growth Factor Research (33 papers) and Growth Hormone and Insulin-like Growth Factors (31 papers). Peter Böhlen is often cited by papers focused on Angiogenesis and VEGF in Cancer (45 papers), Fibroblast Growth Factor Research (33 papers) and Growth Hormone and Insulin-like Growth Factors (31 papers). Peter Böhlen collaborates with scholars based in United States, France and Switzerland. Peter Böhlen's co-authors include Sidney Udenfriend, Stanley J. Stein, Wallace Dairman, Frederick Esch, Roger Guillemin, Nicholas Ling, Andrew Baird, Daniel J. Hicklin, Paul Brazeau and Denis Gospodarowicz and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Peter Böhlen

221 papers receiving 25.8k citations

Hit Papers

Fluorescamine: A Reagent ... 1972 2026 1990 2008 1972 1973 1992 1982 2000 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range
    1972 2.4k citations Peter Böhlen et al. profile →
  2. Fluorometric assay of proteins in the nanogram range
    1973 1.5k citations Peter Böhlen et al. profile →
  3. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
    1992 1.3k citations Peter Böhlen et al. Biochemical and Biophysical Research Communications profile →
  4. Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
    1982 1.0k citations Roger Guillemin, Paul Brazeau et al. profile →
  5. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
    2000 956 citations Daniel J. Hicklin, Peter Böhlen et al. profile →
  6. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.
    1985 609 citations Frederick Esch, Andrew Baird et al. profile →
  7. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
    1987 585 citations Marijke Fràter‐Schröder, Peter Böhlen et al. profile →
  8. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis
    2003 582 citations Beate Heissig, Rafael Tejada et al. Nature Medicine profile →
  9. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    1999 557 citations Marie Prewett, Yiwen Li et al. PubMed profile →
  10. A male accessory gland peptide that regulates reproductive behavior of female D. melanogaster
    1988 546 citations Peter Böhlen et al. profile →
  11. γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE1
    1977 417 citations Peter Böhlen et al. Journal of Neurochemistry profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Böhlen 15.8k 4.6k 3.8k 3.5k 3.5k 223 27.7k
William J. Henzel 16.3k 1.0× 4.2k 0.9× 4.3k 1.1× 3.3k 0.9× 2.9k 0.9× 117 28.6k
Andrew P. Halestrap 22.5k 1.4× 2.6k 0.6× 4.0k 1.0× 2.4k 0.7× 4.1k 1.2× 228 35.3k
John M. Chirgwin 18.4k 1.2× 5.9k 1.3× 2.6k 0.7× 2.5k 0.7× 2.4k 0.7× 122 31.4k
Enrique Rozengurt 22.2k 1.4× 5.1k 1.1× 2.8k 0.7× 1.5k 0.4× 5.2k 1.5× 504 32.9k
Yoshio Yazaki 17.8k 1.1× 2.4k 0.5× 1.8k 0.5× 3.1k 0.9× 2.3k 0.7× 442 35.5k
Alan Przybyla 14.4k 0.9× 2.7k 0.6× 1.7k 0.4× 1.8k 0.5× 1.7k 0.5× 43 24.7k
Joachim Herz 15.9k 1.0× 4.3k 0.9× 5.4k 1.4× 2.6k 0.7× 5.2k 1.5× 284 35.7k
Bruce E. Kemp 31.0k 2.0× 4.4k 1.0× 2.8k 0.7× 4.7k 1.3× 2.4k 0.7× 451 44.8k
Peter Herrlich 20.6k 1.3× 6.3k 1.4× 4.5k 1.2× 2.0k 0.6× 2.0k 0.6× 263 32.6k
Pedro Cuatrecasas 23.0k 1.5× 2.4k 0.5× 1.2k 0.3× 3.2k 0.9× 6.6k 1.9× 362 35.6k

Countries citing papers authored by Peter Böhlen

Since Specialization
Citations

This map shows the geographic impact of Peter Böhlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Böhlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Böhlen more than expected).

Fields of papers citing papers by Peter Böhlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Böhlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Böhlen. The network helps show where Peter Böhlen may publish in the future.

Co-authorship network of co-authors of Peter Böhlen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Böhlen. A scholar is included among the top collaborators of Peter Böhlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Böhlen. Peter Böhlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Meilin, Haifan Zhang, Xenia Jimenez, et al.. (2004). Identification and characterization of a fully human antibody directed against epidermal growth factor receptor for cancer therapy. Cancer Research. 64. 163–163. 14 indexed citations
2.
Prewett, Marie, James R. Tonra, Rajiv Bassi, et al.. (2004). Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models. Cancer Research. 64. 1235–1235. 13 indexed citations
3.
Wu, Yan, Zhaojing Zhong, Huiling Li, et al.. (2004). A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers. Cancer Research. 64. 694–695. 1 indexed citations
4.
Bandt, Michel De, Véronique Ollivier, M Grossin, et al.. (2003). Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis. The Journal of Immunology. 171(9). 4853–4859. 103 indexed citations
5.
Zimmermann, Ralf, Ennian Xiao, Peter Böhlen, & Michel Ferin. (2002). Administration of Antivascular Endothelial Growth Factor Receptor 2 Antibody in the Early Follicular Phase Delays Follicular Selection and Development in the Rhesus Monkey. Endocrinology. 143(7). 2496–2502. 57 indexed citations
6.
Liao, Fang, Jacqueline Doody, Jay Overholser, et al.. (2002). Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.. PubMed. 62(9). 2567–75. 86 indexed citations
7.
Miao, Hua‐Quan, Elizabeth Navarro, Sheetal Patel, et al.. (2002). Cloning, expression, and purification of mouse heparanase. Protein Expression and Purification. 26(3). 425–431. 35 indexed citations
8.
Hattori, Koichi, Beate Heissig, Yan Wu, et al.. (2002). Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment. Nature Medicine. 8(8). 841–849. 491 indexed citations
9.
Liao, Francesca‐Fang, Yiwen Li, William O’Connor, et al.. (2000). Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.. PubMed. 60(24). 6805–10. 99 indexed citations
10.
Kussie, Paul, Jeffrey D. Hulmes, Dale L. Ludwig, et al.. (1999). Cloning and Functional Expression of a Human Heparanase Gene. Biochemical and Biophysical Research Communications. 261(1). 183–187. 170 indexed citations
11.
12.
Baird, Andrew & Peter Böhlen. (1991). Fibroblast Growth Factors. PubMed. 45(2). 369–418. 307 indexed citations
13.
Madden, John J., Christopher J. Evans, Andrew N. Tyler, et al.. (1991). Isolation and Characterization of Opioid Peptides from Rabbit Cerebellum. Journal of Neurochemistry. 56(6). 1914–1920. 2 indexed citations
14.
Fràter‐Schröder, Marijke, Gertraud Müller, Walter Birchmeier, & Peter Böhlen. (1986). Transforming growth factor-beta inhibits endothelial cell proliferation. Biochemical and Biophysical Research Communications. 137(1). 295–302. 263 indexed citations
15.
Petrides, Petro E., et al.. (1985). Isolation and characterization of epidermal growth factor from human milk. FEBS Letters. 187(1). 89–95. 40 indexed citations
16.
Böhlen, Peter, Frederick Esch, Tamotsu Shibasaki, et al.. (1981). Isolation and characterization of a γ1‐melanotropin‐like peptide from bovine neurointermediate pituitary. FEBS Letters. 128(1). 67–70. 37 indexed citations
17.
Brazeau, Paul, Nicholas Ling, Frederick Esch, et al.. (1981). High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regulatory Peptides. 1(4). 255–264. 99 indexed citations
18.
Palfreyman, Michael G., et al.. (1980). The effect of γ-vinyl GABA and γ-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat. Brain Research. 190(1). 288–292. 15 indexed citations
19.
Petrides, Petro E., Richard T. Jones, & Peter Böhlen. (1980). Reverse-phase high-performance liquid chromatography of proteins: The separation of hemoglobin chain variants. Analytical Biochemistry. 105(1). 383–388. 29 indexed citations
20.
Böhlen, Peter, Paul Brazeau, Robert Benoit, et al.. (1980). Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: Somatostatin-28 and somatostatin-25. Biochemical and Biophysical Research Communications. 96(2). 725–734. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William J. Henzel Breakdown of academic impact, for papers by Andrew P. Halestrap Breakdown of academic impact, for papers by John M. Chirgwin Breakdown of academic impact, for papers by Enrique Rozengurt Breakdown of academic impact, for papers by Yoshio Yazaki Breakdown of academic impact, for papers by Alan Przybyla Breakdown of academic impact, for papers by Joachim Herz Breakdown of academic impact, for papers by Bruce E. Kemp Breakdown of academic impact, for papers by Peter Herrlich Breakdown of academic impact, for papers by Pedro Cuatrecasas
Rankless by CCL
2026